Psychiatry & Neurology Doctors in Pleasant Hill, CA Accepting Medicare

8 Psychiatry & Neurology doctors found. Showing 1 - 8

Rujul Rakeshkumar Desai, MD Medicare: Medicare Enrolled Practice Location: 400 Taylor Blvd Ste 306, Pleasant Hill, CA 94523 Phone: 925-691-9688

Owen B Towery, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3478 Buskirk Ave,, Suite 219, Pleasant Hill, CA 94523 Phone: 925-934-0800    Fax: 925-952-4032

Janet Fh Lin, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 400 Taylor Blvd, Suite 301, Pleasant Hill, CA 94523 Phone: 925-602-7060    Fax: 925-602-7070

Dr. Howard J. Weisman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1950 Geary Rd, Pleasant Hill, CA 94523 Phone: 510-333-8520    Fax: 925-287-9011

Carey Fritz, LMFT Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 391 Taylor Blvd Bldg Suite100, Pleasant Hill, CA 94523 Phone: 925-608-6570

Richard M. Leavitt, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3480 Buskirk Ave Ste 210, Pleasant Hill, CA 94523 Phone: 925-933-2627

Steven J Holtz, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 400 Taylor Blvd, Suite 301, Pleasant Hill, CA 94523 Phone: 925-602-7060    Fax: 925-602-7070

Brad A Volpi, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 400 Taylor Blvd, Suite 301, Pleasant Hill, CA 94523 Phone: 925-602-7060    Fax: 925-602-7070

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Access Pharmaceuticals reports significant progress in Cobalamin-targeted drug-delivery program for siRNA therapies

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced today that it has made significant progress with its proprietary Cobalamin-targeted drug-delivery program for siRNA therapies.

Attacking HIV at the source

A new study published on November 26, 2019, in the journal Cell Reports, details a new discovery that may help avert HIV infection right at the start. The virus is known to take a long time to infect a person, and the scientists say they have found a period during which it can be weakened or killed, in the very first hours after it has entered a host. They call this the window of vulnerability.

Researchers identify new mechanism to create lasting memories; findings may yield potential treatment for memory impairments

Researchers at the Swedish medical university Karolinska Institutet have discovered a mechanism that controls the brain's ability to create lasting memories. In experiments on genetically manipulated mice, they were able to switch on and off the animals' ability to form lasting memories by adding a substance to their drinking water. The findings, which are published in the scientific journal PNAS, are of potential significance to the future treatment of Alzheimer's and stroke.

Read more Medical News

› Verified 1 days ago